🇺🇸 FDA
Patent

US 9663585

Anti-DCLK1 monoclonal antibodies and methods of production and use thereof

granted A61KA61K2039/505A61K31/7088

Quick answer

US patent 9663585 (Anti-DCLK1 monoclonal antibodies and methods of production and use thereof) held by The Board of Regents of the University of Oklahoma expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K31/7088, A61K45/06, A61K47/6871